Results 1 to 10 of about 62,245 (203)
Lebrikizumab for adolescent atopic dermatitis: 24-week real-world outcomes from the Czech BIOREP registry. [PDF]
Rob F +7 more
europepmc +1 more source
Clinical profile of ocular allergy and its impact on quality of life in Brazilian children and adolescents. [PDF]
Marino LM +6 more
europepmc +1 more source
Case Series: Combination of dupilumab and omalizumab as a way to reduce dupilumab-associated adverse events in severe atopic dermatitis. [PDF]
Fomina DS +7 more
europepmc +1 more source
Allergic Reactions to Brimonidine 0.15%: A Case Series. [PDF]
Mat Nawi FN, Bastion MC.
europepmc +1 more source
Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary Centre. [PDF]
Abraheem A +5 more
europepmc +1 more source

